Publication | Closed Access

Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischemia–reperfusion injury in mice with metabolic disorders

Metabolic SyndromeCardiovascular DiseaseMedicineMyocardial InfarctionPhysiologyCardiovascular PharmacologyMyocardial Ischemia–reperfusion InjuryVascular BiologyPharmacotherapyMetabolic DisordersMetabolic SignalingPharmacologyOxidative StressHealth Sciences